Sam Lee
Net Worth
Last updated:
What is Sam Lee net worth?
The estimated net worth of Dr. Sam Lee is at least $24,145,964 as of 23 Dec 2016. He owns shares worth $20,047,964 as insider, has earned $968,000 from insider trading and has received compensation worth at least $3,130,000 in Cocrystal Pharma, Inc..
What is the salary of Sam Lee?
Dr. Sam Lee salary is $313,000 per year as Co-Founder, Interim Co-Chief Executive Officer & Pres in Cocrystal Pharma, Inc..
How old is Sam Lee?
Dr. Sam Lee is 65 years old, born in 1960.
What stocks does Sam Lee currently own?
As insider, Dr. Sam Lee owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | Co-Founder, Interim Co-Chief Executive Officer & Pres | 13,087,847 | $1.53 | $20,047,964 |
What does Cocrystal Pharma, Inc. do?
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that is in preclinical development trials for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections; and drug discovery collaboration with HitGen and InterX Inc. The company is headquartered in Bothell, Washington.
Sam Lee insider trading
Cocrystal Pharma, Inc.
Dr. Sam Lee has made only one insider trade between 2015-2016, according to the Form 4 filled with the SEC. He sold 2,200,000 units of COCP stock worth $968,000 on 23 Dec 2016.
As of 23 Dec 2016 he still owns at least 13,087,847 units of COCP stock.
Cocrystal Pharma key executives
Cocrystal Pharma, Inc. executives and other stock owners filed with the SEC:
- Dr. Roger D. Kornberg Ph.D. (78) Co-Founder, Chairman & Scientific Advisory Board and Chief Scientist
- Dr. Sam Lee (65) Co-Founder, Interim Co-Chief Executive Officer & Pres
- Mr. James J. Martin CPA, CPA, M.B.A., MBA (58) Interim Co-Chief Executive Officer, Chief Financial Officer & Corporation Sec.